GE HealthCare has announced that its Allia Moveo image-guidance platform has received US Food and Drug Administration (FDA) 510(k) clearance and CE mark.
The latest Allia platform was first unveiled at the Radiological Society of North America’s (RSNA) 2025 annual meeting (30 November–4 December, Chicago, USA). GE says that the new system will assist clinicians in a wide range of cardiovascular, vascular, non-vascular, interventional and surgical procedures.
New features include a compact, cable-free C-arm system and artificial intelligence (AI)-powered guidance tools to help clinicians work efficiently and adapt to the spatial constraints of traditional interventional suites.
The Hôpital Marie-Lannelongue in Le Plessis-Robinson, France—a center of excellence in thoracic, vascular and heart surgery, and national reference for complex aortic pathologies—was the first medical centre in the world to complete the installation of Allia Moveo. The platform is intended to enable flexible cone-beam computed tomography (CT) and support this leading hospital in treating vascular and cardiology diseases.
“My initial experience with Allia Moveo has been incredible, it’s a real game changer. With Allia Moveo, we had this opportunity to position the system very quickly in any working position that will adapt the best to us,” said Stephan Haulon, vascular surgeon and head of Aortic Center and Vascular Surgery at Hôpital Marie-Lannelongue, part of the Fondation Hôpital Saint-Joseph (Paris, France). “One of the major milestones of this new system is having access to the reconstruction of the cone beam CT with CleaRecon DL, which is AI driven and gives you much better image quality.”
As interventional procedures grow more demanding, clinicians need imaging solutions that deliver clear insights and optimise workflows, GE HealthCare says in a press release. Allia Moveo was created to deliver an easy-to-use, high-performance system, built to enhance fluidity when space is at a premium, the company adds.
“With Allia Moveo, we’re elevating the clinician experience, removing complexity, accelerating workflow, and enabling greater control during procedures,” said Arnaud Marie, general manager, Interventional Solutions at GE HealthCare. “We are excited to collaborate with leading experts at Hôpital Marie-Lannelongue on the first installation of this system, which is a defining step forward for care in the interventional suite, and a testament to our shared commitment to advancing meaningful innovation with the goal of supporting better outcomes for care teams and the patients they treat.”
Following the first global installation of Allia Moveo at Hôpital Marie-Lannelongue, Houston’s Baylor St Luke’s Medical Center, marked the first installation in the USA.
“We are honoured to be the first hospital in the USA to install Allia Moveo, and proud to help advance the next generation of interventional care,” said Brad Lembke, president of Baylor St Luke’s Medical Center (Houston, USA). “This innovative platform enhances how our clinicians navigate complex minimally invasive procedures by improving mobility, image clarity, and workflow efficiency. It strengthens our ability to deliver precise, patient-centred care while supporting our teams with technology designed for the evolving demands of modern interventional medicine.”
